Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 David, 1988, Rudolf Virchow and modern aspects of tumor pathology, Pathol. Res. Pract., 183, 356, 10.1016/S0344-0338(88)80138-9 Madeddu, 2014, Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer, J. Cell Mol. Med., 18, 2519, 10.1111/jcmm.12413 Pierce, 2009, Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors, Breast Cancer Res. Treat., 114, 155, 10.1007/s10549-008-9985-5 Berg, 1959, Inflammation and prognosis in breast cancer; a search for host resistance, Cancer, 12, 714, 10.1002/1097-0142(195907/08)12:4<714::AID-CNCR2820120414>3.0.CO;2-B Cole, 2009, Chronic inflammation and breast cancer recurrence, J. Clin. Oncol., 27, 3418, 10.1200/JCO.2009.21.9782 Snoussi, 2005, Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma, Eur. Cytokine Netw., 16, 253 Constantinou, 2013, Inflammation and breast cancer, Breast Cancer Manag., 2, 311, 10.2217/bmt.13.26 Disis, 2010, Immune regulation of cancer, J. Clin. Oncol., 28, 4531, 10.1200/JCO.2009.27.2146 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Chiang, 2008, Molecular basis of metastasis, N. Engl. J. Med., 359, 2814, 10.1056/NEJMra0805239 Dethlefsen, 2013, The role of intratumoral and systemic IL-6 in breast cancer, Breast Cancer Res. Treat., 138, 657, 10.1007/s10549-013-2488-z Zhang, 1999, Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma, Anticancer Res., 19, 1427 Knupfer, 2007, Significance of interleukin-6 (IL-6) in breast cancer (review), Breast Cancer Res. Treat., 102, 129, 10.1007/s10549-006-9328-3 Sander, 2010, Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function, J. Exp. Med., 207, 1453, 10.1084/jem.20091474 Heys, 1998, Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival, Int. J. Oncol., 13, 589 Siemes, 2006, C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study, J. Clin. Oncol., 24, 5216, 10.1200/JCO.2006.07.1381 Dossus, 2014, C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study, Cancer Causes Control, 25, 533, 10.1007/s10552-014-0355-9 DeMichele, 2003, Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer, Cancer Res., 63, 8051 Decensi, 2007, Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users, J. Clin. Oncol., 25, 4201, 10.1200/JCO.2006.09.4318 Cui, 2014, Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women, Breast Cancer Res. Treat., 146, 439, 10.1007/s10549-014-3030-7 Kim, 2006, Tumor-driven evolution of immunosuppressive networks during malignant progression, Cancer Res., 66, 5527, 10.1158/0008-5472.CAN-05-4128 Korkaya, 2011, Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots, Clin. Cancer Res., 17, 6125, 10.1158/1078-0432.CCR-10-2743 Coronella, 2001, Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer, Cancer Res., 61, 7889 Kryczek, 2011, IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer, J. Immunol., 186, 4388, 10.4049/jimmunol.1003251 Minton, 2005, B cells lead the way in tumour progression, Nat. Rev. Cancer, 5, 10.1038/nrc1662 Tomer, 1998, Autoantibodies, autoimmunity and cancer (review), Oncol. Rep., 5, 753 Rajagopalan, 1996, Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability, J. Clin. Invest., 98, 2572, 10.1172/JCI119076 Leek, 2002, Tumor-associated macrophages in breast cancer, J. Mammary Gland. Biol. Neoplasia, 7, 177, 10.1023/A:1020304003704 Whitford, 1992, Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients, Cancer Lett., 61, 157, 10.1016/0304-3835(92)90174-T Morton, 1986, Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer, Cancer Res., 46, 2121 Wernicke, 1975, Quantitative morphologic assessment of immunoreactivity in regional lymph nodes of patients with carcinoma of the breast, Surg. Gynecol. Obstet., 140, 919 Urdiales-Viedma, 1986, Correlation of histologic grade and lymph node status with some histopathologic discriminants in breast cancer, Tumori, 72, 43, 10.1177/030089168607200107 Shimokawara, 1982, Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera, Cancer, 49, 1456, 10.1002/1097-0142(19820401)49:7<1456::AID-CNCR2820490724>3.0.CO;2-# Lee, 1997, Angiogenesis and inflammation in ductal carcinoma in situ of the breast, J. Pathol., 181, 200, 10.1002/(SICI)1096-9896(199702)181:2<200::AID-PATH726>3.0.CO;2-K Piura, 2010, Autoantibodies to tumor-associated antigens in breast carcinoma, J. Oncol., 2010 Shimada, 2009, Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma, World J. Surg., 33, 272, 10.1007/s00268-008-9821-4 Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 Lin, 2004, Role of infiltrated leucocytes in tumour growth and spread, Br. J. Cancer, 90, 2053, 10.1038/sj.bjc.6601705 Donato, 2004, Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells, Exp. Cell Res., 294, 523, 10.1016/j.yexcr.2003.11.021 Landskron, 2014, Chronic inflammation and cytokines in the tumor microenvironment, J. Immunol. Res., 2014, 19 Bhatelia, 2014, TLRs: linking inflammation and breast cancer, Cell Signal, 26, 2350, 10.1016/j.cellsig.2014.07.035 Brown, 2001, Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer, Breast Cancer Res., 3, 323, 10.1186/bcr315 Khanzode, 2004, Antioxidant enzymes and lipid peroxidation in different stages of breast cancer, Free Radic. Res., 38, 81, 10.1080/01411590310001637066 Haklar, 2001, Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors, Cancer Lett., 165, 219, 10.1016/S0304-3835(01)00421-9 Malins, 1991, Major alterations in the nucleotide structure of DNA in cancer of the female breast, Cancer Res., 51, 5430 Malins, 1993, The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk, Cancer, 71, 3036, 10.1002/1097-0142(19930515)71:10<3036::AID-CNCR2820711025>3.0.CO;2-P Duffy, 2000, Metalloproteinases: role in breast carcinogenesis, invasion and metastasis, Breast Cancer Res., 2, 252, 10.1186/bcr65 Sternlicht, 2001, How matrix metalloproteinases regulate cell behavior, Annu. Rev. Cell Dev. Biol., 17, 463, 10.1146/annurev.cellbio.17.1.463 Matos, 2003, Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling, J. Biol. Chem., 278, 50442, 10.1074/jbc.M308215200 Schnelzer, 2000, Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b, Oncogene, 19, 3013, 10.1038/sj.onc.1203621 Bocca, 2014, Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness, Expert Opin. Ther. Targets, 18, 121, 10.1517/14728222.2014.860447 Subbaramaiah, 2012, Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women, Cancer Discov., 2, 356, 10.1158/2159-8290.CD-11-0241 Singh, 2007, Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells, J. Surg. Res., 140, 220, 10.1016/j.jss.2007.01.039 Zhao, 2003, Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase, Cancer Cell, 3, 483, 10.1016/S1535-6108(03)00088-6 Bos, 2001, Levels of hypoxia-inducible factor-1α during breast carcinogenesis, J. Natl. Cancer Inst., 93, 309, 10.1093/jnci/93.4.309 Ono, 2008, Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy, Cancer Sci., 99, 1501, 10.1111/j.1349-7006.2008.00853.x van Golen, 2002, Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer, Clin. Exp. Metastasis, 19, 301, 10.1023/A:1015518114931 Hamed, 2012, Apoptosis, angiogenesis, inflammation, and oxidative stress: basic interactions in patients with early and metastatic breast cancer, J. Cancer Res. Clin. Oncol., 138, 999, 10.1007/s00432-012-1176-4 Degenhardt, 2006, Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis, Cancer Cell, 10, 51, 10.1016/j.ccr.2006.06.001 Lefort, 2014, Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers, Autophagy, 10, 2122, 10.4161/15548627.2014.981788 Mathew, 2009, Autophagy suppresses tumorigenesis through elimination of p62, Cell, 137, 1062, 10.1016/j.cell.2009.03.048 Mazure, 2010, Hypoxia-induced autophagy: cell death or cell survival?, Curr. Opin. Cell Biol., 22, 177, 10.1016/j.ceb.2009.11.015 Rohatgi, 2015, Beclin 1 regulates growth factor receptor signaling in breast cancer, Oncogene, 16, 5352, 10.1038/onc.2014.454 Kim, 2011, Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation, J. Biol. Chem., 286, 12924, 10.1074/jbc.M110.138958 Tanno, 2011, Development and maintenance of cancer stem cells under chronic inflammation, J. Nippon. Med. Sch., 78, 138, 10.1272/jnms.78.138 Ogmundsdottir, 1995, Interactions between the immune system and breast cancer, Acta Oncol., 34, 647, 10.3109/02841869509094042 Marotta, 2011, The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors, J. Clin. Invest., 121, 2723, 10.1172/JCI44745 Agnihotri, 2013, Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer, Breast Cancer Res., 15, 202, 10.1186/bcr3371 Smith, 2014, NF-kappaB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression, PLoS One, 9, e106966, 10.1371/journal.pone.0106966 Hoesel, 2013, The complexity of NF-kappaB signaling in inflammation and cancer, Mol. Cancer, 12, 86, 10.1186/1476-4598-12-86 Huber, 2004, NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression, J. Clin. Invest., 114, 569, 10.1172/JCI200421358 Yamaguchi, 2009, Constitutive activation of nuclear factor-κB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines, Cancer Sci., 100, 1668, 10.1111/j.1349-7006.2009.01228.x Arlt, 2012, The 'N-factors' in pancreatic cancer: functional relevance of NF-kappaB, NFAT and Nrf2 in pancreatic cancer, Oncogenesis, 1, e35, 10.1038/oncsis.2012.35 Niu, 2012, DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion, J. Biol. Chem., 287, 21783, 10.1074/jbc.M112.355495 Gustin, 2006, Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52, J. Biol. Chem., 281, 16473, 10.1074/jbc.M507373200 Hayden, 2006, NF-kappaB and the immune response, Oncogene, 25, 6758, 10.1038/sj.onc.1209943 Nakshatri, 1997, Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth, Mol. Cell. Biol., 17, 3629, 10.1128/MCB.17.7.3629 Shapochka, 2012, Relationship between NF-kappaB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer, Exp. Oncol., 34, 358 Shao, 2012, Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase, Transl. Cancer Res., 1, 100 Arlt, 2009, Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2), Oncogene, 28, 3983, 10.1038/onc.2009.264 Wang, 2008, Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2, Carcinogenesis, 29, 1235, 10.1093/carcin/bgn095 Valdivia-Silva, 2009, Effect of pro-inflammatory cytokine stimulation on human breast cancer: implications of chemokine receptor expression in cancer metastasis, Cancer Lett., 283, 176, 10.1016/j.canlet.2009.03.040 Wakabayashi, 2010, When NRF2 talks, who's listening?, Antioxid. Redox Signal., 13, 1649, 10.1089/ars.2010.3216 Liu, 2008, NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK, Biochim. Biophys. Acta, 1783, 713, 10.1016/j.bbamcr.2008.01.002 Healy, 2005, Divergent responses of chondrocytes and endothelial cells to shear stress: cross-talk among COX-2, the phase 2 response, and apoptosis, Proc. Natl. Acad. Sci. U. S. A., 102, 14010, 10.1073/pnas.0506620102 Chen, 2005, Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells, Biochem. Biophys. Res. Commun., 331, 993, 10.1016/j.bbrc.2005.03.237 Manna, 2000, Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation, J. Immunol., 164, 6509, 10.4049/jimmunol.164.12.6509 Balogun, 2003, Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells, Biochem. Biophys. Res. Commun., 308, 950, 10.1016/S0006-291X(03)01517-1 Gan, 2013, A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-kappaB and Nrf2-Keap1 signaling pathways, Toxicol. Appl. Pharmacol., 272, 852, 10.1016/j.taap.2013.07.011 Kumar, 2013, Ethyl 3',4',5'-trimethoxythionocinnamate modulates NF-kappaB and Nrf2 transcription factors, Eur. J. Pharmacol., 700, 32, 10.1016/j.ejphar.2012.12.004 Yu, 2014, Revisiting STAT3 signalling in cancer: new and unexpected biological functions, Nat. Rev. Cancer, 14, 736, 10.1038/nrc3818 Taga, 1989, Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130, Cell, 58, 573, 10.1016/0092-8674(89)90438-8 Darnell, 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 10.1126/science.8197455 Stark, 1998, How cells respond to interferons, Annu. Rev. Biochem., 67, 227, 10.1146/annurev.biochem.67.1.227 Yu, 2007, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat. Rev. Immunol., 7, 41, 10.1038/nri1995 Yu, 2004, The STATs of cancer – new molecular targets come of age, Nat. Rev. Cancer, 4, 97, 10.1038/nrc1275 Vultur, 2004, Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells, Oncogene, 23, 2600, 10.1038/sj.onc.1207378 Berishaj, 2007, Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer, Breast Cancer Res., 9, R32, 10.1186/bcr1680 Yu, 2009, STATs in cancer inflammation and immunity: a leading role for STAT3, Nat. Rev. Cancer, 9, 798, 10.1038/nrc2734 Bromberg, 2000, The role of STATs in transcriptional control and their impact on cellular function, Oncogene, 19, 2468, 10.1038/sj.onc.1203476 Gritsko, 2006, Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells, Clin. Cancer Res., 12, 11, 10.1158/1078-0432.CCR-04-1752 Diaz, 2006, Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression, Clin. Cancer Res., 12, 20, 10.1158/1078-0432.CCR-04-1749 Dolled-Filhart, 2003, Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis, Clin. Cancer Res., 9, 594 Kortylewski, 2008, Role of Stat3 in suppressing anti-tumor immunity, Curr. Opin. Immunol., 20, 228, 10.1016/j.coi.2008.03.010 Eyking, 2011, Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer, Gastroenterology, 141, 2154, 10.1053/j.gastro.2011.08.043 Pelletier, 2003, Rho family gtpases are required for activation of Jak/STAT signaling by G protein-coupled receptors, Mol. Cell. Biol., 23, 1316, 10.1128/MCB.23.4.1316-1333.2003 Guo, 2013, Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition, Oncogene, 32, 5272, 10.1038/onc.2012.573 Deng, 2012, S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites, Cancer Cell, 21, 642, 10.1016/j.ccr.2012.03.039 Chang, 2013, The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis, Neoplasia, 15, 848, 10.1593/neo.13706 Lee, 2012, Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation, Proc. Natl. Acad. Sci. U. S. A., 109, 7765, 10.1073/pnas.1205132109 Wu, 2014, Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation, PLoS One, 9, e93478, 10.1371/journal.pone.0093478 Vivanco, 2002, The phosphatidylinositol 3-Kinase AKT pathway in human cancer, Nat. Rev. Cancer, 2, 489, 10.1038/nrc839 Brazil, 2001, Ten years of protein kinase B signalling: a hard Akt to follow, Trends Biochem. Sci., 26, 657, 10.1016/S0968-0004(01)01958-2 Datta, 1997, Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, 91, 231, 10.1016/S0092-8674(00)80405-5 Kucab, 2005, Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours, Breast Cancer Res., 7, R796, 10.1186/bcr1294 Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science, 307, 1098, 10.1126/science.1106148 Prueitt, 2007, Inflammation and IGF-I activate the Akt pathway in breast cancer, Int. J. Cancer, 120, 796, 10.1002/ijc.22336 Pollak, 2004, Insulin-like growth factors and neoplasia, Nat. Rev. Cancer, 4, 505, 10.1038/nrc1387 Datta, 2002, Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis, Dev. Cell, 3, 631, 10.1016/S1534-5807(02)00326-X Cardone, 1998, Regulation of cell death protease caspase-9 by phosphorylation, Science, 282, 1318, 10.1126/science.282.5392.1318 Arun, 2004, The role of COX-2 inhibition in breast cancer treatment and prevention, Semin. Oncol., 31, 22, 10.1053/j.seminoncol.2004.03.042 Glynn, 2010, COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer, BMC Cancer, 10, 626, 10.1186/1471-2407-10-626 Renehan, 2004, Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis, Lancet, 363, 1346, 10.1016/S0140-6736(04)16044-3 Di Popolo, 2000, IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells, Oncogene, 19, 5517, 10.1038/sj.onc.1203952 Luo, 2003, Targeting the PI3K-Akt pathway in human cancer: rationale and promise, Cancer Cell, 4, 257, 10.1016/S1535-6108(03)00248-4 Bjornsti, 2004, The TOR pathway: a target for cancer therapy, Nat. Rev. Cancer, 4, 335, 10.1038/nrc1362 Kaminska, 2005, MAPK signalling pathways as molecular targets for anti-inflammatory therapy–from molecular mechanisms to therapeutic benefits, Biochim. Biophys. Acta (BBA) Proteins Proteomics, 1754, 253, 10.1016/j.bbapap.2005.08.017 Krens, 2006, Functions of the MAPK family in vertebrate-development, FEBS Lett., 580, 4984, 10.1016/j.febslet.2006.08.025 Huang, 2010, MAPK signaling in inflammation-associated cancer development, Protein Cell, 1, 218, 10.1007/s13238-010-0019-9 Dhillon, 2007, MAP kinase signalling pathways in cancer, Oncogene, 26, 3279, 10.1038/sj.onc.1210421 Wagner, 2009, Signal integration by JNK and p38 MAPK pathways in cancer development, Nat. Rev. Cancer, 9, 537, 10.1038/nrc2694 Sebolt-Leopold, 2004, Targeting the mitogen-activated protein kinase cascade to treat cancer, Nat. Rev. Cancer, 4, 937, 10.1038/nrc1503 Roberts, 2007, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, 26, 3291, 10.1038/sj.onc.1210422 Gupta, 2015, Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer, FEBS J., 282, 1841, 10.1111/febs.13250 Han, 2007, [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer], Ai Zheng, 26, 48 Takkouche, 2008, Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis, J. Natl. Cancer Inst., 100, 1439, 10.1093/jnci/djn324 Harris, 2003, Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the women's health initiative, Cancer Res., 63, 6096 Zhao, 2009, Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis, Breast Cancer Res. Treat., 117, 141, 10.1007/s10549-008-0228-6 Gierach, 2008, Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study, Breast Cancer Res., 10, R38, 10.1186/bcr2089